Thalidomide-associated deep vein thrombosis and pulmonary embolism
- 1 November 2002
- journal article
- review article
- Published by Elsevier in The American Journal of Medicine
- Vol. 113 (7) , 603-606
- https://doi.org/10.1016/s0002-9343(02)01300-1
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Temozolomide Plus Thalidomide in Patients With Advanced Melanoma: Results of a Dose-Finding TrialJournal of Clinical Oncology, 2002
- Thromboembolic events during treatment with thalidomideBlood, 2002
- Thalidomide and Venous ThrombosisAnnals of Internal Medicine, 2002
- Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapyBlood, 2001
- Extended survival in advanced and refractory multiple myeloma after single-agent thalidomide: identification of prognostic factors in a phase 2 study of 169 patientsBlood, 2001
- Deep Venous Thrombosis and Thalidomide Therapy for Multiple MyelomaNew England Journal of Medicine, 2001
- Thalomid?? (Thalidomide) CapsulesDrug Safety, 2001
- Antitumor Activity of Thalidomide in Refractory Multiple MyelomaNew England Journal of Medicine, 1999
- Thalidomide is an inhibitor of angiogenesis.Proceedings of the National Academy of Sciences, 1994
- THALIDOMIDE AND CONGENITAL ABNORMALITIESThe Lancet, 1961